Understanding Public Attitudes Towards the COVID-19 Vaccination

NCT05023512 | Withdrawn

• 2 other identifiers: H000236721OT2HL156812-01
• Study Type: interventional
• Target: N/A
• Locations: 0 countries
• Sites: N/A

Brief Summary

The objective of this study is to better understand public attitudes towards coronavirus disease 2019 (COVID-19) vaccination. This understanding will inform the development of community engagement strategies to be used in future interventions and studies aimed at addressing factors that impact the disproportionate burden of COVID-19 in under-served and vulnerable communities.

Conditions

Covid19; Vaccination

Outcome Measures

Primary Outcomes (1)

• Intent to be vaccinated against Covid-19 among unvaccinated participants

  The survey includes a question that assesses participants' willingness to be vaccinated against Covid-19 if they are unvaccinated. Responses include Yes, No, or Not Sure to being vaccinated against Covid-19.

  Through survey completion, an average of 12 minutes

Study Arms (2)

Message 1

EXPERIMENTAL

Participants will be randomized to receive version #1 of 2 different versions of a message from the Massachusetts Department of Public Health regarding the COVID-19 vaccination.

Behavioral: Communication about the COVID-19 vaccination from the Massachusetts Department of Public Health

Message 2

EXPERIMENTAL

Participants will be randomized to receive version #2 of 2 different versions of a message from the Massachusetts Department of Public Health regarding the COVID-19 vaccination.

Behavioral: Communication about the COVID-19 vaccination from the Massachusetts Department of Public Health

Interventions

Communication about the COVID-19 vaccination from the Massachusetts Department of Public Health BEHAVIORAL

Participants will be randomized to receive one of two different versions of messages from the Massachusetts Department of Public Health. The message that participants in each experimental group receive will vary slightly and systematically. Specific content and wording of these messages were developed to address and mitigate concerns about the Covid-19 vaccination.

Message 1; Message 2

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Massachusetts resident
• Adult (age 18 and over)
• English or Spanish speaking

You may not qualify if:

• Non-English or Spanish speaking

Sponsors & Collaborators

• University of Massachusetts, Worcester: lead
• Boston University: collaborator
• National Heart, Lung, and Blood Institute (NHLBI): collaborator

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Kimberly Fisher, MD

  University of Massachusetts, Worcester

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: FACTORIAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor

Study Record Dates

• First Submitted: August 24, 2021
• First Posted: August 26, 2021
• Study Start: October 28, 2021
• Primary Completion: July 15, 2022
• Study Completion: September 1, 2022
• Last Updated: June 6, 2022

Record last verified: 2022-06

Data Sharing

• IPD Sharing: Will not share